Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole as Salvage Treatment for Pulmonary Aspergillosis
NCT02020213Phase 4Withdrawn
- Sponsor
- Taichung Veterans General Hospital
- Start
- Dec 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of posaconazole in aspergillosis, sponsored by Taichung Veterans General Hospital. Planned start Dec 2013; status: withdrawn.
02
Drugs
posaconazole
03
Conditions
aspergillosis
Beyond the preview
Go deeper on NCT02020213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02020213.